A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer-Reference-Cited by-同舟云学术

A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer

Published:1994-01 Issue:2 Volume:30 Page:188-194
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Eguchi Kenji,Etou Hisashi,Miyachi Sumiki,Morinari Hajime,Nakada Kouichiro,Noda Kazumasa,Ohkuni Yoshihiro,Watanabe Koshiro,Yamada Yuzuru,Ohe Yuichiro,Tamura Tomohide,Sasaki Yasutsuna,Shinkai Tetsu,Saijo Nagahiro

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Therapy of small cell lung cancer: a perspective on two decades of clinical research;Seifter;Semin Oncol,1988

2. Intensive chemotherapy of small cell lung cancer;Klastersky;Lung Cancer,1989

3. Chemotherapy of lung cancer;Ihde;N Engl J Med,1992

4. Carboplatin, etoposide, and ifosphamide as intensive chemotherapy for small-cell lung cancer;Smith;J Clin Oncol,1990

5. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer;Johnson;J Clin Oncol,1987

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. History of Japan Clinical Oncology Group (JCOG) Lung Cancer Study Group;Japanese Journal of Clinical Oncology;2020-03-02

2. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer;European Journal of Cancer;2003-11

3. Japan Clinical Oncology Group (JCOG);Japanese Journal of Clinical Oncology;1998-03-01

4. Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?;Journal of Cancer Research and Clinical Oncology;1998-03

5. A Comparative Review of Colony-Stimulating Factors;Drugs;1997-11